{"ticker": {"uuid": "91b52e9f-e26e-4cb3-af1d-eefb9c92dad8", "symbol": "TMDX", "name": "TransMedics Group Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "TransMedics Group (TMDX) Stock Still Looks Below Fair Value After A 154% Run", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T07:28:19+00:00", "published_display": "17 Jul 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group Inc (TMDX) Stock Price Quote Today & Current Price Chart | Capital.com EU", "summary": "This page provides current stock information for TransMedics Group Inc (TMDX), including its stock price quote, key statistics, and a company overview. It highlights TMDX as a medical technology company focused on organ transplant therapy with its OCS products. The article also t", "url": "https://capital.com/en-eu/markets/shares/transmedics-group-inc-share-price", "source_name": "Capital.com", "published_at": "2026-07-16T14:40:20", "published_display": "16 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regency Capital Management Inc. DE Purchases Shares of 21,846 TransMedics Group, Inc. $TMDX", "summary": "Regency Capital Management Inc. DE has acquired 21,846 shares of TransMedics Group, Inc. (NASDAQ:TMDX) valued at approximately $2.17 million during the first quarter. This makes Regency Capital Management Inc. DE the owner of about 0.06% of the company's stock. Insider transactio", "url": "https://www.marketbeat.com/instant-alerts/filing-regency-capital-management-inc-de-purchases-shares-of-21846-transmedics-group-inc-tmdx-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T11:12:16", "published_display": "16 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) 44th Annual J.P. Morgan Healthcare Conference Summary", "summary": "TransMedics Group (TMDX) provided a summary of their 44th Annual J.P. Morgan Healthcare Conference, outlining significant strategic, technological, clinical, and operational advancements. Key points include plans for a new facility in Somerville, the development of their OCS mult", "url": "https://quartr.com/events/transmedics-group-tmdx-44th-annual-j-p-morgan-healthcare-conference_3gI0T49U", "source_name": "Quartr", "published_at": "2026-07-16T01:39:37", "published_display": "16 Jul 2026 01:39", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) CEO receives major RSU and stock option grants", "summary": "TransMedics Group's President & CEO, Waleed H. Hassanein, received significant equity awards on July 10, 2026, including 49,669 restricted stock units and stock options for 112,984 shares at an exercise price of $71.23. These options will vest monthly until April 2030, contingent", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-a0d2110422ea.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:12:16", "published_display": "15 Jul 2026 12:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) awards RSUs and stock options to officer", "summary": "TransMedics Group (TMDX) has granted equity compensation to officer Nicholas Corcoran, including 11,727 restricted stock units (RSUs) and a stock option for 17,784 shares. The stock option has an exercise price of $71.23 per share and vests monthly, with full vesting expected by ", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-86b64bcc7352.html", "source_name": "Stock Titan", "published_at": "2026-07-15T02:43:31", "published_display": "15 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ: TMDX) grants CFO 17,246 RSUs and 26,153 stock options", "summary": "TransMedics Group's CFO, Gerardo Hernandez, was granted 17,246 Restricted Stock Units (RSUs) and 26,153 stock options on July 10, 2026. The stock options have an exercise price of $71.23 per share and will vest monthly from April 10, 2026, through April 10, 2030. Following these ", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-acea980121b3.html", "source_name": "Stock Titan", "published_at": "2026-07-15T02:43:31", "published_display": "15 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 TransMedics Group Inc For: 14 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for TransMedics Group Inc (TMDX) on July 14th. Form 4s disclose transactions made by company insiders. The brief news piece provides no further details on the specific transactions but notes the company's stock performanc", "url": "https://ng.investing.com/news/stock-market-news/form-4-transmedics-group-inc-for-14-july-93CH-2599770", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T01:43:31", "published_display": "15 Jul 2026 01:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TransMedics Group Jumps 6.7% Amid Sector-Wide Rally", "summary": "TransMedics Group's stock surged 6.7% to $75.97, reflecting a broad rally across the medical device sector rather than company-specific news. The organ transplant technology company's market capitalization reached $2.7 billion with significant trading volume, outperforming peers ", "url": "https://news.alphastreet.com/transmedics-group-jumps-6-7-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-07-14T12:12:16", "published_display": "14 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Sees 8% Surge, Trading at $76.90", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPYTkyYUlTNEhvWVpJQzV4cVowbDNiUUJFaWhTTW00UFc3MU8tVTVic1VFb0pDdFpIbm4tU2M5WXFJZng2bl84ci14U2I1Y2k1eHNaTm9EaTFUdWdfRGxmekFMWlQtanBUcTZxLXc5MkJRRFlySWx6U3Y4ZERZOEdXWFA5TjIzVWdNTmt6SA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-13T16:45:39+00:00", "published_display": "13 Jul 2026 16:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ:TMDX) Shares Up 6.3% - Time to Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPcVplcDhma2d4QXA0N3U5YWtGZXluQ2llUTltUWlDT3ZHdWRZZTZmU09FODMtQ291c3Azamtsd3pRaUlFODBtWGJ3OFhxbDhzSTZVMWQ2WjZZOC13dnY2ZUJtRFpCeXBKcVNnNl9OUXBMM3VBVUVsQ2pGc2Z4MmVQaHNUWlZaaVNScWFva2tUZTd0ZHdVTElQWlpFaDJULXRBRFRFYXRzZDlLck0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T15:42:42+00:00", "published_display": "13 Jul 2026 15:42", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Buys 49,580 Shares of TransMedics Group, Inc. $TMDX", "summary": "Candriam S.C.A. increased its holdings in TransMedics Group, Inc. by 45.4% in the first quarter, purchasing an additional 49,580 shares to bring its total to 158,766 shares valued at $15.8 million. Other institutional investors also adjusted their positions, while Director Thomas", "url": "https://www.marketbeat.com/instant-alerts/filing-candriam-sca-buys-49580-shares-of-transmedics-group-inc-tmdx-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T15:10:17", "published_display": "12 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Proxy filing Summary", "summary": "TransMedics Group (TMDX) has filed a proxy statement proposing an amendment to its 2019 Stock Incentive Plan. The amendment seeks to add 2,750,000 shares and enhance governance, supporting the company's significant growth from $30 million in revenue in 2021 to $605.5 million in 2", "url": "https://quartr.com/events/transmedics-group-tmdx-proxy-filing_3gI0TbPE", "source_name": "Quartr", "published_at": "2026-07-11T08:42:37", "published_display": "11 Jul 2026 08:42", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q3 2025 earnings summary", "summary": "TransMedics Group (TMDX) reported strong Q3 2025 results, with revenue reaching $143.8 million, a 32.2% year-over-year increase, and net income soaring to $24.3 million. The growth was driven by increased OCS utilization, particularly in liver and heart transplants through the Na", "url": "https://quartr.com/events/transmedics-group-tmdx-q3-2025_3gI0RHIi", "source_name": "Quartr", "published_at": "2026-07-08T22:42:37", "published_display": "08 Jul 2026 22:42", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q1 2026 earnings summary", "summary": "TransMedics Group (TMDX) announced Q1 2026 revenue of $173.9 million, a 21% year-over-year increase, driven by OCS Liver sales, NOP usage, and logistics services. Despite growth, gross margin declined to 58%, and operating expenses rose due to investments. The company reiterated ", "url": "https://quartr.com/events/transmedics-group-tmdx-q1-2026_3gI0TOrE", "source_name": "Quartr", "published_at": "2026-07-08T15:11:00", "published_display": "08 Jul 2026 15:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Expands Into Europe, Is The Stock Still Undervalued?", "summary": "TransMedics Group (TMDX) has expanded into Europe by investing in Germany-based PAD Aviation, aiming to replicate its Organ Care System Network Operating Platform and build a pan-European organ transplant logistics network. Despite recent stock declines, at US$71.12, the company ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-group-tmdx-expands-into-europe-is-the-stock-stil", "source_name": "Simply Wall Street", "published_at": "2026-07-08T11:09:44", "published_display": "08 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQS3pUSXBYTmF5QlBSN3VBRFV5RkVVaUhrM1gxR1VoR1M1TEdoQUhkazNxNG9pVlk3VkJDaVNNTk04VWlydkZMRC1adG5INVVoRG9qWnZQN3EzYW1Xa3pkVWpnZ0duSkFRckVVQ1EzYTN5NDZNRzFZelIwUTJZLUJ3R216YXZjcEpxa3JraGo4a2o2LTFWYVZLNQ?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10 Best Innovative Healthcare Stocks to Buy Now", "summary": "TransMedics Group, Inc. (NASDAQ:TMDX) is highlighted as an innovative healthcare stock, with 40 hedge funds holding stakes. The company recently announced a strategic investment in PAD Aviation to expand its Organ Care System (OCS) program into Europe, aiming to enhance organ tra", "url": "https://www.insidermonkey.com/blog/10-best-innovative-healthcare-stocks-to-buy-now-1797028/2/", "source_name": "Insider Monkey", "published_at": "2026-07-07T21:09:00", "published_display": "07 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH", "summary": "TransMedics Group, Inc. has announced the completion of its strategic investment in PAD Aviation service GmbH, a German-based private aviation operator. This investment is crucial for TransMedics to establish a dedicated pan-European organ transplantation air logistics network, a", "url": "https://www.prnewswire.com/news-releases/transmedics-group-announces-completion-of-strategic-investment-in-pad-aviation-service-gmbh-302818049.html", "source_name": "PR Newswire", "published_at": "2026-07-06T10:39:44", "published_display": "06 Jul 2026 10:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMDX - Transmedics Group Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Transmedics Group Inc (TMDX), along with comprehensive financial data. It includes key figures such as market capitalization, income, sales, various financial ratios, stock performance metrics, and analyst recommendatio", "url": "https://finviz.com/stock?t=TMDX&p=d&b=2&r=y1&ty=lf&page=4", "source_name": "Finviz", "published_at": "2026-07-03T21:10:25", "published_display": "03 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Where Will TransMedics Group Stock Be in 10 Years?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOQmJILXVMV2t6aU1KejhxcEVXYzNld1VfV21kdElVaS12UTl2RFNQcXV1Wi03TEt1RnRqaFBRbEl2TVBoX0NocE12dTlYX2lfanUxV1RSU3EzTFJDeDBCWGF6SVBRTVlYX3lhVzBkVEVhcUVVX3JLMVJTYThyaGN4Y1ZVdktMSGNkdDFNZDVNYw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Stock Looks Undervalued On Earnings While Risks Cloud Fair Value", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Growth Stocks to Buy on the Dip", "summary": "This article suggests three growth stocks\u2014SoFi Technologies, Robinhood Markets, and TransMedics Group\u2014that investors should consider buying after recent dips in their stock prices. Despite facing challenges such as short-seller reports or disappointing quarterly results, all thre", "url": "https://www.theglobeandmail.com/investing/markets/stocks/NVDA-Q/pressreleases/3108254/3-growth-stocks-to-buy-on-the-dip/", "source_name": "The Globe and Mail", "published_at": "2026-07-02T23:09:26", "published_display": "02 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMDX Stock Rallies As Analyst Sees 77% Upside \u2014 Here\u2019s Why", "summary": "TransMedics Group Inc (TMDX) stock rallied after TD Cowen maintained a 'Buy' rating and a $120 price target, citing strong growth in U.S. transplant activity, particularly in heart, liver, and lung procedures, as a key driver for the company's Organ Care System (OCS) technology a", "url": "https://fr.tradingview.com/news/stocktwits:2d410a4dd094b:0-tmdx-stock-rallies-as-analyst-sees-77-upside-here-s-why/", "source_name": "TradingView", "published_at": "2026-07-02T08:09:26", "published_display": "02 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics: The Margins Must Recover (NASDAQ:TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQc2FwYlpoY2h2VXhrY3JxNU0wYTc1ak5taU8weGJyd2poRm91bW1YMWZCcXBQSDRNVmMtaGNpQnEwUGllNHBMeEVkeWRmTlRrMWQ4Y25oRDRYRXNDa0pNaThPcy0yN1NZRGNQUmVmWFdlVVVNdlhibm1jNjc5QS1JalhyTQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain TransMedics Stock in Your Portfolio for Now", "summary": "TransMedics Group, Inc. (TMDX) is positioned for growth due to its innovative Organ Care System (OCS) technology and solid first-quarter 2026 results. Despite a year-to-date stock decline and gross margin pressures, the company's robust pipeline, including next-generation OCS sys", "url": "https://www.tradingview.com/news/zacks:c7cb735b7094b:0-reasons-to-retain-transmedics-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-06-30T17:09:18", "published_display": "30 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Canaccord Genuity Group", "summary": "Canaccord Genuity Group has reiterated a \"buy\" rating for TransMedics Group (NASDAQ:TMDX) with a $124.00 price target, suggesting a potential upside of 88.28%. Despite this, the stock was down 2.1% to $65.86, trading well below its 52-week high. The company's recent earnings show", "url": "https://www.marketbeat.com/instant-alerts/transmedics-group-nasdaqtmdx-earns-buy-rating-from-canaccord-genuity-group-2026-06-30/", "source_name": "MarketBeat", "published_at": "2026-06-30T16:09:18", "published_display": "30 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (TMDX) Price Events", "summary": "This article provides an AI-generated liquidity mapping and trading strategies for Transmedics Group Inc. (NASDAQ: TMDX). Key findings indicate near-term weak sentiment, with no clear price positioning signal and elevated downside risk. The analysis offers specific institutional ", "url": "https://news.stocktradersdaily.com/news_release/16/Liquidity_Mapping_Around_TMDX_Price_Events_062926073802_1782733082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T07:38:00", "published_display": "29 Jun 2026 07:38", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of TransMedics Group, Inc. \u2013 NASDAQ:TMDX", "summary": "The article provides a snapshot of the forward price-to-sales ratio for TransMedics Group, Inc. (NASDAQ: TMDX). While the specific value is not detailed in the provided text, it indicates that the information regards a financial metric for the company. The content appears to be a", "url": "https://www.tradingview.com/symbols/NASDAQ-TMDX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T10:09:54", "published_display": "28 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz", "summary": "Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by TransMedics Group, Inc. (TMDX). The firm is encouraging investors who purchased TransMedics securities prior to February 3, 2022, and still hold them, to contact them to learn", "url": "https://www.natlawreview.com/press-releases/transmedics-group-inc-tmdx-investigation-bronstein-gewirtz-grossman-llc", "source_name": "The National Law Review", "published_at": "2026-06-27T18:40:16", "published_display": "27 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Actuals & Estimates (NASDAQ:TMDX)", "summary": "This article provides an overview of TransMedics Group, Inc. (NASDAQ: TMDX) stock, including its current price, historical performance, analyst forecasts, and financial data. It details key metrics like market capitalization, earnings, revenue, and EBITDA, while also offering ins", "url": "https://www.tradingview.com/symbols/NASDAQ-TMDX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:35", "published_display": "26 Jun 2026 17:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Trade Ideas \u2014 DUS:8T8", "summary": "This article compiles various trade ideas and analyses for TransMedics Group, Inc. (DUS:8T8, NASDAQ:TMDX) from different contributors on TradingView. The discussions cover recent price action, earnings reports, technical indicators like EMAs and support/resistance levels, and fun", "url": "https://www.tradingview.com/symbols/DUS-8T8/ideas/page-2/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:52", "published_display": "26 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Actuals & Estimates (MUN:8T8)", "summary": "This article provides an overview of TransMedics Group, Inc. (MUN:8T8) stock, including its current price, performance, analyst forecasts, and financial data. It highlights the company's valuation metrics, market capitalization, earnings, revenue, and employee count. The article ", "url": "https://www.tradingview.com/symbols/MUN-8T8/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:40:52", "published_display": "26 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group clears fresh high, shares trade firmly on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRWF0TEZxRW84UnBWcGlmdmEzWENxMzZnUlRVdkt3anRWZ240NWE1a0Z6dnZjN2J2Q3p1WUE0SXBxbzFmaGg5eENQRmVRYU5qdUxhdWdGTFNvX2hyU0Q3QnNNM2IxdDR0ZzdNUlJfTkRMd2FuRXkycDhIT3Jub2thdEkxRUY4c0hOemh3MDZyel9MWk11SVlCNUVjeGFyZ2c0MEJFd2hPSnV4VHRJcmUydVJqQVJCQmlCdG94bDJCWWUwUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckJtTHVsb2t0S0pQdVItSm9hTUQ0TGJKZkdnYWJMOWthU19ZSmVxVldxMkRkOWx1RzZJWTVrcEZ6RWxsdjBxdEFBT1R3M3pXa21wVlZDVFRlQ1E2RVNLT3F6OGUwZmFCRlA2UUlhdEE0Qk9RUWx1TDFSY0lLU1o2WXBTN1duclQxdWJaU05zNTVEUkp0OVM5NGd4amJ4SFM1Q2d3Z2lQWjNJVWpuZGlvdVg4TS1keXdwNC1vc1lkMkc2LU0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Will Analyst Focus on TransMedics\u2019 OCS Platform and Financial Metrics Change TransMedics Group\u2019s (TMDX) Narrative?", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/analyst-focus-transmedics-ocs-platform-201758545.html", "source_name": "Simply Wall St.", "published_at": "2026-06-06T20:17:58+00:00", "published_display": "06 Jun 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVkpvS1dIN3Zkd3pTREozMElsM2x4cGQ5QlFkNjlqWktneEdKb1NvQ1BPanM1VlNEREIzZXM1NTloNU9BXzVkYmdQb3kxNXdpUUhhRU5VVVAza3pmUG93WjdJZVBhbjZnWkE3QWkxbW9QV1NZS1dBc0toLXFoRF9MUXlJZ2dkMFFkSHMwVGw5U2lpenYx?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/transmedics-reports-inducement-grants-under-200500421.html", "source_name": "PR Newswire", "published_at": "2026-05-21T20:05:00+00:00", "published_display": "21 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group stock (US89366D3075): organ transplant tech in focus after conference appearance", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNajlqNEVwTWhXZzdyeU0xdHRZakhIN1czWEFzNUw5Q0V3WEtpUGtERmJLSm9Heko3cVBqVlloVDhfX2RmM2VRMWVGZ2JFTnc3X0xqSi1oam5qLXMxcDE0YkRqcG5nXzNpaVRNZ3BmMVYxR01hdGZGdmVCUXNnbzNqMlZ2YUNZd3c4Zzltb3V6NUhpSjJKZ1ZhRlV6aDRVM0UwdGlycjhFSkpJWXpoR1Fwbmo2a0pfcmJNaEhFU0NFQUpQUFFn?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMTNLLTl5ajRLOFl3YnpGeU9xZHJPR0RvUmtNUjJ5emNqYVl3ZHZJY3hBZWZDTHV3eHl2dVJZM05BeC1VbW9QclFwRlRFMnhUejJYcUNQUENja0xlbkdJM2U0eGtZYlJrcUdnM0Vod1Fid05NbWF0SVYxRC1nVlpGQ3BlaEJyOGFxTUE5eHgxRmtKbl9qOGJBLUR3eHRLUWpiUkE2engtU2JxQWc?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q1 EPS Lull Tests Bullish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics owns 22 aircraft, enters PAD deal for Europe transplants", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNEI3U3c2VkJRd2xwcFNRNkptVlpvbEZONTR1eUZFQ1JvLWVVZThadnhjSV9iOFJDQnpKUzZqbUpFWjFzVjNpTEdwNUtDaUhraTNyZHhDY1JNZnRkaC1BU0xhQ2xqc0RGN0FIakJVS3A0VDBCekQ1NHZLZjBIaGNLZHhKaXlWdDJtWVdDSXVxc3VaNHNQS3oyWlMyNlRyd1BqaGhaR3JSaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNVFlPeHFGUlRoc2ZOajNCR29IZ2J6VWxaeEE4RGlqclc3b0k4WjdBSkw0cWo0ZDlUTy1XV0ltcWtQdURaV2hJX0ZoUjAwNEpqcjR0UUJrdkhDNG1QTlhtamZWQ1FFOFdtTVRzRzhNQ3ZqNHlXejNzZEhYdDZTVTR5YjhPY19jdG5hTmlGNzhXZUcwQlVDaW55QmZMTkg2dEJuWXVz?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPaEJXNHphdFdMU3c0TWRFRWpJWDFPSDhVSVhhY0tPR2Y3dVFtVUFFcFU1WmNUbW5fWWU2dzJwdjNrRF9MX09TV2xNNE5jR1VXN3NBeWtqelM0cjE4RVdIQUNIa3I2bFUzeWlIM3YtTFZZc0FqemROQkRTSGVTQ3ZxOHVOaWJaSUZBclo0RmE5ZDBJQzNjZzZZZzdYYXI?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TransMedics Expands OCS Program As Kidney And Lung Platform Story Grows", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPdExsVWVqTFFraTlLTC0yVGFnSkhqc3VCbTBrUnlneUdUOWZzQXlmakxCUjNmX0xmblpRUmZwN0ZGSVczZXpvazJOSnV4WFJYV2NKeHVwU2NIZ095UkhxRDhyNE1qZ2FiaW5WS2RmUk9kVDlJSFBpb2paX1RaZ0swbHF5NVVWQnliRG9rY25DS2YxSmpoVVlQZHllbWprYmY4Q3MyMU5ZNUIwSnJiX0owX0xmeTJZUF9fc0ZVMzh4VUVRYVBtSWRXY0U3WWoybXZwZGpn0gHYAUFVX3lxTE5ydF9rYVpwcHd5RUZMT0dNQ2VIMUJTWWRuR0xwb0xMaENKbW1iaTFyMXUyRExOUmFtQVlwYkZGVmw0Uzc3QXBiRU1MZndPbF9jNlRXNDljOXJoc2twd3hiQnpIblMzVWpyOTFSUFFvZW4zN2RyS2NKRjI2OFo4VllOODY3NUhmQ2hOclllTUV4enhfZUQyR1JwT0FtNkJjUGtWUHl0MEIwX0VkX2Z5RFRmeHIzSzRDV2RuWnNzZ2JZbVp4TjZ5dGlSS1puQkNvTFRYRE1NM0F4RQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNN21nLW5VSDNJZUNvWXRaOUpUOEp6U2FQZnFLczdmWGR5d0RFRldnODlDUHRiLUdGallrZklpeTltV29UX0NaMi16bG9sbXhYSDJZQzhXaV9ZbTQxYzJWOEtZbWRLNTlDRkVFcTNIR0tqZzd0V0k4VkZYcWV1aWtwSFdfTTgzZHJsaTd0VlpveFVnUnJjQWc?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPNGIxSHdQR1pUNDJsR3lmVXU1N3hPSXdpNUt1ZzhUMjRfLVVTVGwyRklpdmFacmFrT1lWLVJySTJvaXllYmZJSEdIZGRpbVA3NllsRWZPbVNLOFlSUkIwR3VPekt5QmZ2NkY1a2RPQjFNWE14VnRxNG14QncyOGZjXzc0YTNpcFR0eVFpV0owcjJOcUZGYUphbURXQTd2emMxZV9ZbGRNdUNVeW1CdkNqaU9pNC1DWEJB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPZEFwR3NJcDg1MVN6RzFDc0FxaGRqakhQVURTWDkwMzd1NnBGTXhhRXNKVW9zbW8wVGt3eGNmWDIyUHRGUlMwelRHYzNoRk1nOHJRaXNGLWFHZHpLbmVxTWlraWp2QnZrcEtaX3UtOGplTnZTN0h0Q2tLeHNKVHA3VTJUWl9mQmtiWTRkb3VDNFB5SFNvSHFjdjZpQ2tkSVVGLTFuNld2MTZrZTNYZXI1Umk2NG4wck40SndSWWVNQVBlSThHRlE?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNWWFMSndiSHMxMmZzd2tUVU5iajZibDZWRXR3WnZKSDE5SFMxbi02cmJkNDFlOVFlNjFOMjdleHZKZlN1X2dvODRHSXU4eno3WmZZY0hoRTQ1Ty1nZFphZ3dCTUpqSTdtQVNxYTNUaVV1dU5jYzZkZVlFOWg3YUE1aXd6Umt0bXJXZHZoQlBvLWxveVVMazU3a2N1dmlvZHlFaW1yVXhfclZUZjNkWFFsNTJqUHZMcXlfb3JocQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNSlduNlJFVHZCUHhsU192dUlkSXRfTGc5U1hfbVdpQkRHb3d4WUV3b1lUYkgySUxaajNhcjJVNl9RY2VZVllkOEdfWk04UnlpcGJzVk5aQURmd0J6emthR21ESnAyalFPeXp3Q0U2TkVUYm41MFQyaHpZZnU3REM1UkFBRFRhTGROUHlwV21vcl9yTXdzMG4wMjZuclprMDVJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "TransMedics Group (TMDX) Stock Still Looks Below Fair Value After A 154% Run", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T07:28:19+00:00", "published_display": "17 Jul 2026 07:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group Inc (TMDX) Stock Price Quote Today & Current Price Chart | Capital.com EU", "summary": "This page provides current stock information for TransMedics Group Inc (TMDX), including its stock price quote, key statistics, and a company overview. It highlights TMDX as a medical technology company focused on organ transplant therapy with its OCS products. The article also t", "url": "https://capital.com/en-eu/markets/shares/transmedics-group-inc-share-price", "source_name": "Capital.com", "published_at": "2026-07-16T14:40:20", "published_display": "16 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regency Capital Management Inc. DE Purchases Shares of 21,846 TransMedics Group, Inc. $TMDX", "summary": "Regency Capital Management Inc. DE has acquired 21,846 shares of TransMedics Group, Inc. (NASDAQ:TMDX) valued at approximately $2.17 million during the first quarter. This makes Regency Capital Management Inc. DE the owner of about 0.06% of the company's stock. Insider transactio", "url": "https://www.marketbeat.com/instant-alerts/filing-regency-capital-management-inc-de-purchases-shares-of-21846-transmedics-group-inc-tmdx-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T11:12:16", "published_display": "16 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) 44th Annual J.P. Morgan Healthcare Conference Summary", "summary": "TransMedics Group (TMDX) provided a summary of their 44th Annual J.P. Morgan Healthcare Conference, outlining significant strategic, technological, clinical, and operational advancements. Key points include plans for a new facility in Somerville, the development of their OCS mult", "url": "https://quartr.com/events/transmedics-group-tmdx-44th-annual-j-p-morgan-healthcare-conference_3gI0T49U", "source_name": "Quartr", "published_at": "2026-07-16T01:39:37", "published_display": "16 Jul 2026 01:39", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) CEO receives major RSU and stock option grants", "summary": "TransMedics Group's President & CEO, Waleed H. Hassanein, received significant equity awards on July 10, 2026, including 49,669 restricted stock units and stock options for 112,984 shares at an exercise price of $71.23. These options will vest monthly until April 2030, contingent", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-a0d2110422ea.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:12:16", "published_display": "15 Jul 2026 12:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) awards RSUs and stock options to officer", "summary": "TransMedics Group (TMDX) has granted equity compensation to officer Nicholas Corcoran, including 11,727 restricted stock units (RSUs) and a stock option for 17,784 shares. The stock option has an exercise price of $71.23 per share and vests monthly, with full vesting expected by ", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-86b64bcc7352.html", "source_name": "Stock Titan", "published_at": "2026-07-15T02:43:31", "published_display": "15 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ: TMDX) grants CFO 17,246 RSUs and 26,153 stock options", "summary": "TransMedics Group's CFO, Gerardo Hernandez, was granted 17,246 Restricted Stock Units (RSUs) and 26,153 stock options on July 10, 2026. The stock options have an exercise price of $71.23 per share and will vest monthly from April 10, 2026, through April 10, 2030. Following these ", "url": "https://www.stocktitan.net/sec-filings/TMDX/form-4-trans-medics-group-inc-insider-trading-activity-acea980121b3.html", "source_name": "Stock Titan", "published_at": "2026-07-15T02:43:31", "published_display": "15 Jul 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 TransMedics Group Inc For: 14 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for TransMedics Group Inc (TMDX) on July 14th. Form 4s disclose transactions made by company insiders. The brief news piece provides no further details on the specific transactions but notes the company's stock performanc", "url": "https://ng.investing.com/news/stock-market-news/form-4-transmedics-group-inc-for-14-july-93CH-2599770", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T01:43:31", "published_display": "15 Jul 2026 01:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group Jumps 6.7% Amid Sector-Wide Rally", "summary": "TransMedics Group's stock surged 6.7% to $75.97, reflecting a broad rally across the medical device sector rather than company-specific news. The organ transplant technology company's market capitalization reached $2.7 billion with significant trading volume, outperforming peers ", "url": "https://news.alphastreet.com/transmedics-group-jumps-6-7-amid-sector-wide-rally/", "source_name": "AlphaStreet", "published_at": "2026-07-14T12:12:16", "published_display": "14 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Sees 8% Surge, Trading at $76.90", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPYTkyYUlTNEhvWVpJQzV4cVowbDNiUUJFaWhTTW00UFc3MU8tVTVic1VFb0pDdFpIbm4tU2M5WXFJZng2bl84ci14U2I1Y2k1eHNaTm9EaTFUdWdfRGxmekFMWlQtanBUcTZxLXc5MkJRRFlySWx6U3Y4ZERZOEdXWFA5TjIzVWdNTmt6SA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-13T16:45:39+00:00", "published_display": "13 Jul 2026 16:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ:TMDX) Shares Up 6.3% - Time to Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPcVplcDhma2d4QXA0N3U5YWtGZXluQ2llUTltUWlDT3ZHdWRZZTZmU09FODMtQ291c3Azamtsd3pRaUlFODBtWGJ3OFhxbDhzSTZVMWQ2WjZZOC13dnY2ZUJtRFpCeXBKcVNnNl9OUXBMM3VBVUVsQ2pGc2Z4MmVQaHNUWlZaaVNScWFva2tUZTd0ZHdVTElQWlpFaDJULXRBRFRFYXRzZDlLck0?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-13T15:42:42+00:00", "published_display": "13 Jul 2026 15:42", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Buys 49,580 Shares of TransMedics Group, Inc. $TMDX", "summary": "Candriam S.C.A. increased its holdings in TransMedics Group, Inc. by 45.4% in the first quarter, purchasing an additional 49,580 shares to bring its total to 158,766 shares valued at $15.8 million. Other institutional investors also adjusted their positions, while Director Thomas", "url": "https://www.marketbeat.com/instant-alerts/filing-candriam-sca-buys-49580-shares-of-transmedics-group-inc-tmdx-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T15:10:17", "published_display": "12 Jul 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Proxy filing Summary", "summary": "TransMedics Group (TMDX) has filed a proxy statement proposing an amendment to its 2019 Stock Incentive Plan. The amendment seeks to add 2,750,000 shares and enhance governance, supporting the company's significant growth from $30 million in revenue in 2021 to $605.5 million in 2", "url": "https://quartr.com/events/transmedics-group-tmdx-proxy-filing_3gI0TbPE", "source_name": "Quartr", "published_at": "2026-07-11T08:42:37", "published_display": "11 Jul 2026 08:42", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q3 2025 earnings summary", "summary": "TransMedics Group (TMDX) reported strong Q3 2025 results, with revenue reaching $143.8 million, a 32.2% year-over-year increase, and net income soaring to $24.3 million. The growth was driven by increased OCS utilization, particularly in liver and heart transplants through the Na", "url": "https://quartr.com/events/transmedics-group-tmdx-q3-2025_3gI0RHIi", "source_name": "Quartr", "published_at": "2026-07-08T22:42:37", "published_display": "08 Jul 2026 22:42", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q1 2026 earnings summary", "summary": "TransMedics Group (TMDX) announced Q1 2026 revenue of $173.9 million, a 21% year-over-year increase, driven by OCS Liver sales, NOP usage, and logistics services. Despite growth, gross margin declined to 58%, and operating expenses rose due to investments. The company reiterated ", "url": "https://quartr.com/events/transmedics-group-tmdx-q1-2026_3gI0TOrE", "source_name": "Quartr", "published_at": "2026-07-08T15:11:00", "published_display": "08 Jul 2026 15:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Expands Into Europe, Is The Stock Still Undervalued?", "summary": "TransMedics Group (TMDX) has expanded into Europe by investing in Germany-based PAD Aviation, aiming to replicate its Organ Care System Network Operating Platform and build a pan-European organ transplant logistics network. Despite recent stock declines, at US$71.12, the company ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-group-tmdx-expands-into-europe-is-the-stock-stil", "source_name": "Simply Wall Street", "published_at": "2026-07-08T11:09:44", "published_display": "08 Jul 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQS3pUSXBYTmF5QlBSN3VBRFV5RkVVaUhrM1gxR1VoR1M1TEdoQUhkazNxNG9pVlk3VkJDaVNNTk04VWlydkZMRC1adG5INVVoRG9qWnZQN3EzYW1Xa3pkVWpnZ0duSkFRckVVQ1EzYTN5NDZNRzFZelIwUTJZLUJ3R216YXZjcEpxa3JraGo4a2o2LTFWYVZLNQ?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10 Best Innovative Healthcare Stocks to Buy Now", "summary": "TransMedics Group, Inc. (NASDAQ:TMDX) is highlighted as an innovative healthcare stock, with 40 hedge funds holding stakes. The company recently announced a strategic investment in PAD Aviation to expand its Organ Care System (OCS) program into Europe, aiming to enhance organ tra", "url": "https://www.insidermonkey.com/blog/10-best-innovative-healthcare-stocks-to-buy-now-1797028/2/", "source_name": "Insider Monkey", "published_at": "2026-07-07T21:09:00", "published_display": "07 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH", "summary": "TransMedics Group, Inc. has announced the completion of its strategic investment in PAD Aviation service GmbH, a German-based private aviation operator. This investment is crucial for TransMedics to establish a dedicated pan-European organ transplantation air logistics network, a", "url": "https://www.prnewswire.com/news-releases/transmedics-group-announces-completion-of-strategic-investment-in-pad-aviation-service-gmbh-302818049.html", "source_name": "PR Newswire", "published_at": "2026-07-06T10:39:44", "published_display": "06 Jul 2026 10:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMDX - Transmedics Group Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Transmedics Group Inc (TMDX), along with comprehensive financial data. It includes key figures such as market capitalization, income, sales, various financial ratios, stock performance metrics, and analyst recommendatio", "url": "https://finviz.com/stock?t=TMDX&p=d&b=2&r=y1&ty=lf&page=4", "source_name": "Finviz", "published_at": "2026-07-03T21:10:25", "published_display": "03 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Where Will TransMedics Group Stock Be in 10 Years?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOQmJILXVMV2t6aU1KejhxcEVXYzNld1VfV21kdElVaS12UTl2RFNQcXV1Wi03TEt1RnRqaFBRbEl2TVBoX0NocE12dTlYX2lfanUxV1RSU3EzTFJDeDBCWGF6SVBRTVlYX3lhVzBkVEVhcUVVX3JLMVJTYThyaGN4Y1ZVdktMSGNkdDFNZDVNYw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Stock Looks Undervalued On Earnings While Risks Cloud Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNcVVVUzN2MW8taTVoTlpSQjR2Yzk0cEJjVlVld0FKZ0xhT0Z2VzR5UTg0LVM5azdVbGlybnlNZzVaR3JmODdLUUMyWWVhQ2dXV1ZsSFVWZXR1OWM5cDZlazJ3d1VCMFF5SGJjREFHUnk2dU9BYnB5QXFpMDkxRExWZG13dElaUUthaVJtZG05R0g3LTBBWkVkek43dTFGR3FWanNqakFrLUFrQXU4Z2ZnVXNILS05NC13Y0hQOGY4NEdWVUpuZ2NkREh5NjJqM2VBNEZTStIB2gFBVV95cUxOalBDRXo4T3lxcnl3eXBfMDktaXc4ZzlVdDRwRGJQMEhfMWE3UW9YS0t0cGxEZUZPTzRZYkN1NjVzUk8zRmpkUDRlV0xtakZCeklNRlBjaHUwZ1VLVWMyWV9JUVNUZnBiakpCRXgyWE9feWdGWkc3VUM5Q2lETkRVS0cxNlF1NTlEa2JDNjI3V2xqcWtEVDdPVmJQaXRZX3pyc21CWkg0TU9sVW1JSWtrR3NUV2t1dVoxMU9GYTdrc1dsSVNTVTU0N0Y1eDdjUzFHUUxIWjg3cUlMZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Growth Stocks to Buy on the Dip", "summary": "This article suggests three growth stocks\u2014SoFi Technologies, Robinhood Markets, and TransMedics Group\u2014that investors should consider buying after recent dips in their stock prices. Despite facing challenges such as short-seller reports or disappointing quarterly results, all thre", "url": "https://www.theglobeandmail.com/investing/markets/stocks/NVDA-Q/pressreleases/3108254/3-growth-stocks-to-buy-on-the-dip/", "source_name": "The Globe and Mail", "published_at": "2026-07-02T23:09:26", "published_display": "02 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMDX Stock Rallies As Analyst Sees 77% Upside \u2014 Here\u2019s Why", "summary": "TransMedics Group Inc (TMDX) stock rallied after TD Cowen maintained a 'Buy' rating and a $120 price target, citing strong growth in U.S. transplant activity, particularly in heart, liver, and lung procedures, as a key driver for the company's Organ Care System (OCS) technology a", "url": "https://fr.tradingview.com/news/stocktwits:2d410a4dd094b:0-tmdx-stock-rallies-as-analyst-sees-77-upside-here-s-why/", "source_name": "TradingView", "published_at": "2026-07-02T08:09:26", "published_display": "02 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics: The Margins Must Recover (NASDAQ:TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQc2FwYlpoY2h2VXhrY3JxNU0wYTc1ak5taU8weGJyd2poRm91bW1YMWZCcXBQSDRNVmMtaGNpQnEwUGllNHBMeEVkeWRmTlRrMWQ4Y25oRDRYRXNDa0pNaThPcy0yN1NZRGNQUmVmWFdlVVVNdlhibm1jNjc5QS1JalhyTQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain TransMedics Stock in Your Portfolio for Now", "summary": "TransMedics Group, Inc. (TMDX) is positioned for growth due to its innovative Organ Care System (OCS) technology and solid first-quarter 2026 results. Despite a year-to-date stock decline and gross margin pressures, the company's robust pipeline, including next-generation OCS sys", "url": "https://www.tradingview.com/news/zacks:c7cb735b7094b:0-reasons-to-retain-transmedics-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-06-30T17:09:18", "published_display": "30 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Canaccord Genuity Group", "summary": "Canaccord Genuity Group has reiterated a \"buy\" rating for TransMedics Group (NASDAQ:TMDX) with a $124.00 price target, suggesting a potential upside of 88.28%. Despite this, the stock was down 2.1% to $65.86, trading well below its 52-week high. The company's recent earnings show", "url": "https://www.marketbeat.com/instant-alerts/transmedics-group-nasdaqtmdx-earns-buy-rating-from-canaccord-genuity-group-2026-06-30/", "source_name": "MarketBeat", "published_at": "2026-06-30T16:09:18", "published_display": "30 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (TMDX) Price Events", "summary": "This article provides an AI-generated liquidity mapping and trading strategies for Transmedics Group Inc. (NASDAQ: TMDX). Key findings indicate near-term weak sentiment, with no clear price positioning signal and elevated downside risk. The analysis offers specific institutional ", "url": "https://news.stocktradersdaily.com/news_release/16/Liquidity_Mapping_Around_TMDX_Price_Events_062926073802_1782733082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T07:38:00", "published_display": "29 Jun 2026 07:38", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of TransMedics Group, Inc. \u2013 NASDAQ:TMDX", "summary": "The article provides a snapshot of the forward price-to-sales ratio for TransMedics Group, Inc. (NASDAQ: TMDX). While the specific value is not detailed in the provided text, it indicates that the information regards a financial metric for the company. The content appears to be a", "url": "https://www.tradingview.com/symbols/NASDAQ-TMDX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T10:09:54", "published_display": "28 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz", "summary": "Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by TransMedics Group, Inc. (TMDX). The firm is encouraging investors who purchased TransMedics securities prior to February 3, 2022, and still hold them, to contact them to learn", "url": "https://www.natlawreview.com/press-releases/transmedics-group-inc-tmdx-investigation-bronstein-gewirtz-grossman-llc", "source_name": "The National Law Review", "published_at": "2026-06-27T18:40:16", "published_display": "27 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Actuals & Estimates (NASDAQ:TMDX)", "summary": "This article provides an overview of TransMedics Group, Inc. (NASDAQ: TMDX) stock, including its current price, historical performance, analyst forecasts, and financial data. It details key metrics like market capitalization, earnings, revenue, and EBITDA, while also offering ins", "url": "https://www.tradingview.com/symbols/NASDAQ-TMDX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:35", "published_display": "26 Jun 2026 17:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Trade Ideas \u2014 DUS:8T8", "summary": "This article compiles various trade ideas and analyses for TransMedics Group, Inc. (DUS:8T8, NASDAQ:TMDX) from different contributors on TradingView. The discussions cover recent price action, earnings reports, technical indicators like EMAs and support/resistance levels, and fun", "url": "https://www.tradingview.com/symbols/DUS-8T8/ideas/page-2/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:52", "published_display": "26 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group, Inc. Actuals & Estimates (MUN:8T8)", "summary": "This article provides an overview of TransMedics Group, Inc. (MUN:8T8) stock, including its current price, performance, analyst forecasts, and financial data. It highlights the company's valuation metrics, market capitalization, earnings, revenue, and employee count. The article ", "url": "https://www.tradingview.com/symbols/MUN-8T8/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:40:52", "published_display": "26 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group clears fresh high, shares trade firmly on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRWF0TEZxRW84UnBWcGlmdmEzWENxMzZnUlRVdkt3anRWZ240NWE1a0Z6dnZjN2J2Q3p1WUE0SXBxbzFmaGg5eENQRmVRYU5qdUxhdWdGTFNvX2hyU0Q3QnNNM2IxdDR0ZzdNUlJfTkRMd2FuRXkycDhIT3Jub2thdEkxRUY4c0hOemh3MDZyel9MWk11SVlCNUVjeGFyZ2c0MEJFd2hPSnV4VHRJcmUydVJqQVJCQmlCdG94bDJCWWUwUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckJtTHVsb2t0S0pQdVItSm9hTUQ0TGJKZkdnYWJMOWthU19ZSmVxVldxMkRkOWx1RzZJWTVrcEZ6RWxsdjBxdEFBT1R3M3pXa21wVlZDVFRlQ1E2RVNLT3F6OGUwZmFCRlA2UUlhdEE0Qk9RUWx1TDFSY0lLU1o2WXBTN1duclQxdWJaU05zNTVEUkp0OVM5NGd4amJ4SFM1Q2d3Z2lQWjNJVWpuZGlvdVg4TS1keXdwNC1vc1lkMkc2LU0?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Analyst Focus on TransMedics\u2019 OCS Platform and Financial Metrics Change TransMedics Group\u2019s (TMDX) Narrative?", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/analyst-focus-transmedics-ocs-platform-201758545.html", "source_name": "Simply Wall St.", "published_at": "2026-06-06T20:17:58+00:00", "published_display": "06 Jun 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVkpvS1dIN3Zkd3pTREozMElsM2x4cGQ5QlFkNjlqWktneEdKb1NvQ1BPanM1VlNEREIzZXM1NTloNU9BXzVkYmdQb3kxNXdpUUhhRU5VVVAza3pmUG93WjdJZVBhbjZnWkE3QWkxbW9QV1NZS1dBc0toLXFoRF9MUXlJZ2dkMFFkSHMwVGw5U2lpenYx?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/transmedics-reports-inducement-grants-under-200500421.html", "source_name": "PR Newswire", "published_at": "2026-05-21T20:05:00+00:00", "published_display": "21 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group stock (US89366D3075): organ transplant tech in focus after conference appearance", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNajlqNEVwTWhXZzdyeU0xdHRZakhIN1czWEFzNUw5Q0V3WEtpUGtERmJLSm9Heko3cVBqVlloVDhfX2RmM2VRMWVGZ2JFTnc3X0xqSi1oam5qLXMxcDE0YkRqcG5nXzNpaVRNZ3BmMVYxR01hdGZGdmVCUXNnbzNqMlZ2YUNZd3c4Zzltb3V6NUhpSjJKZ1ZhRlV6aDRVM0UwdGlycjhFSkpJWXpoR1Fwbmo2a0pfcmJNaEhFU0NFQUpQUFFn?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMTNLLTl5ajRLOFl3YnpGeU9xZHJPR0RvUmtNUjJ5emNqYVl3ZHZJY3hBZWZDTHV3eHl2dVJZM05BeC1VbW9QclFwRlRFMnhUejJYcUNQUENja0xlbkdJM2U0eGtZYlJrcUdnM0Vod1Fid05NbWF0SVYxRC1nVlpGQ3BlaEJyOGFxTUE5eHgxRmtKbl9qOGJBLUR3eHRLUWpiUkE2engtU2JxQWc?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Group (TMDX) Q1 EPS Lull Tests Bullish Profitability Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics owns 22 aircraft, enters PAD deal for Europe transplants", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPNEI3U3c2VkJRd2xwcFNRNkptVlpvbEZONTR1eUZFQ1JvLWVVZThadnhjSV9iOFJDQnpKUzZqbUpFWjFzVjNpTEdwNUtDaUhraTNyZHhDY1JNZnRkaC1BU0xhQ2xqc0RGN0FIakJVS3A0VDBCekQ1NHZLZjBIaGNLZHhKaXlWdDJtWVdDSXVxc3VaNHNQS3oyWlMyNlRyd1BqaGhaR3JSaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to Say", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNVFlPeHFGUlRoc2ZOajNCR29IZ2J6VWxaeEE4RGlqclc3b0k4WjdBSkw0cWo0ZDlUTy1XV0ltcWtQdURaV2hJX0ZoUjAwNEpqcjR0UUJrdkhDNG1QTlhtamZWQ1FFOFdtTVRzRzhNQ3ZqNHlXejNzZEhYdDZTVTR5YjhPY19jdG5hTmlGNzhXZUcwQlVDaW55QmZMTkg2dEJuWXVz?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPaEJXNHphdFdMU3c0TWRFRWpJWDFPSDhVSVhhY0tPR2Y3dVFtVUFFcFU1WmNUbW5fWWU2dzJwdjNrRF9MX09TV2xNNE5jR1VXN3NBeWtqelM0cjE4RVdIQUNIa3I2bFUzeWlIM3YtTFZZc0FqemROQkRTSGVTQ3ZxOHVOaWJaSUZBclo0RmE5ZDBJQzNjZzZZZzdYYXI?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Expands OCS Program As Kidney And Lung Platform Story Grows", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNN21nLW5VSDNJZUNvWXRaOUpUOEp6U2FQZnFLczdmWGR5d0RFRldnODlDUHRiLUdGallrZklpeTltV29UX0NaMi16bG9sbXhYSDJZQzhXaV9ZbTQxYzJWOEtZbWRLNTlDRkVFcTNIR0tqZzd0V0k4VkZYcWV1aWtwSFdfTTgzZHJsaTd0VlpveFVnUnJjQWc?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPNGIxSHdQR1pUNDJsR3lmVXU1N3hPSXdpNUt1ZzhUMjRfLVVTVGwyRklpdmFacmFrT1lWLVJySTJvaXllYmZJSEdIZGRpbVA3NllsRWZPbVNLOFlSUkIwR3VPekt5QmZ2NkY1a2RPQjFNWE14VnRxNG14QncyOGZjXzc0YTNpcFR0eVFpV0owcjJOcUZGYUphbURXQTd2emMxZV9ZbGRNdUNVeW1CdkNqaU9pNC1DWEJB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPZEFwR3NJcDg1MVN6RzFDc0FxaGRqakhQVURTWDkwMzd1NnBGTXhhRXNKVW9zbW8wVGt3eGNmWDIyUHRGUlMwelRHYzNoRk1nOHJRaXNGLWFHZHpLbmVxTWlraWp2QnZrcEtaX3UtOGplTnZTN0h0Q2tLeHNKVHA3VTJUWl9mQmtiWTRkb3VDNFB5SFNvSHFjdjZpQ2tkSVVGLTFuNld2MTZrZTNYZXI1Umk2NG4wck40SndSWWVNQVBlSThHRlE?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNWWFMSndiSHMxMmZzd2tUVU5iajZibDZWRXR3WnZKSDE5SFMxbi02cmJkNDFlOVFlNjFOMjdleHZKZlN1X2dvODRHSXU4eno3WmZZY0hoRTQ1Ty1nZFphZ3dCTUpqSTdtQVNxYTNUaVV1dU5jYzZkZVlFOWg3YUE1aXd6Umt0bXJXZHZoQlBvLWxveVVMazU3a2N1dmlvZHlFaW1yVXhfclZUZjNkWFFsNTJqUHZMcXlfb3JocQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNSlduNlJFVHZCUHhsU192dUlkSXRfTGc5U1hfbVdpQkRHb3d4WUV3b1lUYkgySUxaajNhcjJVNl9RY2VZVllkOEdfWk04UnlpcGJzVk5aQURmd0J6emthR21ESnAyalFPeXp3Q0U2TkVUYm41MFQyaHpZZnU3REM1UkFBRFRhTGROUHlwV21vcl9yTXdzMG4wMjZuclprMDVJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 93, "total_relevant": 61, "sentiment_summary": {"positive": 17, "negative": 6, "neutral": 38, "score": 56, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 14.1, "count": 25}, {"event": "earnings", "label": "Earnings", "weight": 12.92, "count": 26}, {"event": "analyst", "label": "Analyst action", "weight": 3.65, "count": 6}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.45, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 71.23, "latest_week": "2026-07-10", "one_week_move": 3.4, "four_week_move": -2.3, "twelve_week_move": -38.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.891256, "market_dynamics_buy_signal": false, "relative_strength": -46.174113, "fair_value_gap": -29.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.1071, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.4% over one week, -2.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "TradingView", "count": 6}, {"label": "Stock Titan", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "MarketBeat", "count": 4}, {"label": "Quartr", "count": 4}, {"label": "PR Newswire", "count": 3}, {"label": "Seeking Alpha", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 51}, {"label": "Industry context", "count": 10}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 26}, {"label": "Market update", "count": 25}, {"label": "Analyst action", "count": 6}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "51", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.4% over one week, -2.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "TransMedics Group (TMDX) Stock Still Looks Below Fair Value After A 154% Run"}], "updated_at": "2026-07-18T05:17:16.986170+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}